Glomus jugulare tumors are rare, normally benign, paragangliomas located in and around the jugular foramen at the base of the skull. They may cause significant lower cranial nerve deficits due to ...
Given the location, combined with slight bony remodeling of the jugular foramen suggestive of a slow growing lesion, the appearance was thought to be consistent with a glomus jugulare tumor (Fig 2).
Belzutifan is under clinical development by Merck and currently in Phase II for Paraganglioma (Glomus Jugulare Tumor). According to GlobalData, Phase II drugs for Paraganglioma (Glomus Jugulare Tumor) ...